Stocks · Healthcare · Biotechnology
Absci Corporation ABSI
$11.53 +4.16% Close, Oct 5, 2026 · NASDAQ · Market cap $1.88B
Strong trendHigh risk
Next earnings report: Nov 16, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -8411.3% from -2846.6% a year earlier.
- The diluted share count rose 23.4% in a year.
- Revenue over the last four quarters was $1.6M, down 62.3% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 9%
- Revenue growth, 3-year CAGRBottom 7%
- Revenue growth accelerationBottom 48%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 24%
- Gross marginBottom 4%
- Operating marginBottom 4%
- Accruals (lower is better)Bottom 41%
- Interest coverBottom 5%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 48%
- Free-cash-flow yieldBottom 48%
- EBITDA / enterprise valueBottom 47%
- Sales / enterprise valueBottom 3%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 11%
- 6-month returnTop 1%
- 1-year return vs S&P 500Top 5%
- Distance from 52-week highTop 8%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 29%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 50%
- Upside to consensus price targetBottom 27%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 14%
- Maximum drawdown, 3 yearsTop 44%
- Beta vs S&P 500 (lower is better)Bottom 6%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -61.9% | -62.3% | ↓ |
| Gross margin | -1281.2% | -255.9% | ↑ |
| Operating margin | -2846.6% | -8411.3% | ↓ |
| FCF margin | -1854.2% | -6981.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -62.3% | -61.9% | ↓ | Bottom 9% |
| Gross margin | -255.9% | -1281.2% | ↑ | Bottom 4% |
| Operating margin | -8411.3% | -2846.6% | ↓ | Bottom 4% |
| Net margin | -7756.4% | -2737.9% | ↓ | — |
| Free-cash-flow margin | -6981.0% | -1854.2% | ↓ | — |
| Return on invested capital | -52.2% | — | Bottom 24% | |
| Revenue growth, 3-year CAGR | -21.3% | — | Bottom 7% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 898.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -37.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -2263.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -9.41%
- Shareholder yield
- -9.41%
- Share count change, 1 year
- +23.4%
- Share count change, 3-year CAGR
- +19.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -9.6%
- Average 2-day reaction, last 8
- -1.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $13.60
- Target vs current price
- +18.0%
- Analysts with a rating
- 13
- Share rating Buy or Strong Buy
- 77%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 11, 2026 | +5.8% | +4.4% | +2.6% | -1.1% | — |
| May 7, 2026 | +5.0% | -3.4% | -10.9% | +23.4% | +33.3% |
| Mar 24, 2026 | -43.8% | +2.7% | -5.8% | +33.1% | +145.1% |
| Nov 12, 2025 | -5.3% | -1.4% | -17.7% | +15.1% | -20.0% |
| Aug 12, 2025 | -26.3% | +4.2% | -0.7% | -10.9% | +38.2% |
| May 13, 2025 | +8.7% | +1.0% | -5.5% | +3.4% | -0.3% |
| Mar 18, 2025 | -13.6% | -4.0% | -3.4% | -3.7% | -6.2% |
| Nov 12, 2024 | -26.3% | -15.0% | -35.3% | -6.1% | +1.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.18 | -$0.19 | +5.8% | $300,000 |
| May 7, 2026 | -$0.19 | -$0.20 | +5.0% | $215,000 |
| Mar 24, 2026 | -$0.23 | -$0.16 | -43.8% | $650,000 |
| Nov 12, 2025 | -$0.20 | -$0.19 | -5.3% | $378,000 |
| Aug 12, 2025 | -$0.24 | -$0.19 | -26.3% | $593,000 |
| May 13, 2025 | -$0.21 | -$0.23 | +8.7% | $1.2M |
| Mar 18, 2025 | -$0.25 | -$0.22 | -13.6% | $665,000 |
| Nov 12, 2024 | -$0.24 | -$0.19 | -26.3% | $1.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1134.58× | — | — | Bottom 3% |
| Free-cash-flow yield | -5.81% | — | — | Bottom 48% |
| Earnings yield | -6.94% | — | — | Top 48% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 13
- Days above the 200-day average
- 121
- 50-day average slope (20 days)
- -1.9%
- 200-day average slope (20 days)
- +11.9%
- Distance from 50-day average
- +27.1%
- Distance from 200-day average
- +95.4%
- RSI (14)
- 66.7
- Relative volume
- 1.06×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 86.4%
- Volatility vs own 5-year history
- 29th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.36
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -0.8%
- Maximum drawdown, 3 years
- -66.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 3, 2021 | Oct 26, 2023 | -96.2% | 562 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.88B
- EPS, diluted (TTM)
- -$0.80
- Revenue (TTM)
- $1.6M
- 52-week range
- $2.24 – $12.06
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $4.8M | $5.7M | $5.7M | $4.5M | $2.8M |
| Gross profit | -$39.8M | -$53.2M | -$41.8M | -$57.9M | -$8.9M |
| Operating income | -$75.2M | -$106.8M | -$115.5M | -$108.9M | -$124.7M |
| Net income | -$101.0M | -$104.9M | -$110.6M | -$103.1M | -$115.2M |
| EPS (diluted) | -$1.11 | -$1.15 | -$1.20 | -$0.94 | -$0.84 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $665,000 | $1.2M | $593,000 | $378,000 | $650,000 | $215,000 | $318,000 |
| Net income | -$27.4M | -$29.0M | -$26.3M | -$30.6M | -$28.7M | -$29.6M | -$29.6M | -$33.2M |
| EPS (diluted) | -$0.24 | -$0.25 | -$0.21 | -$0.24 | -$0.20 | -$0.20 | -$0.19 | -$0.21 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$60.6M | -$81.3M | -$64.6M | -$72.4M | -$92.9M |
| Capital expenditure | -$38.0M | -$16.2M | -$860,000 | -$404,000 | -$1.1M |
| Free cash flow | -$98.6M | -$97.5M | -$65.5M | -$72.8M | -$94.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $210.4M | $656,000 | $862,000 | $86.6M | $109.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $201.1M
- Total assets
- $268.9M
- Total liabilities
- $22.8M
- Total debt
- $3.7M
- Net debt
- -$104.2M
- Shareholders’ equity
- $246.1M
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 37,255,325
- Days to cover
- 14.44
- Change vs previous report
- +1.3%
FINRA short interest, settlement date Sep 15, 2026.